Yes, Tim is offering asian pre-clinicals the opportunity to leverage Adalta's clinical expertise to advance their drugs in western economies.
"Adalta's clinical expertise" as evidenced by how well they have done with AD214 !!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $5.1K | 2.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 21738357 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 4679253 | 11 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |